Home › Therapeutic areas › Neurology › Frontotemporal Dementia
Frontotemporal Dementia (5 companies)
Companies with an active program in Frontotemporal Dementia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ACIU | AC Immune | Neurology Rare | 1 | Phase 3 | $210M | 11 |
| CRVO | CervoMed | Neurology Rare | 1 | Phase 2 | $22.7M | 4 |
| COYA | Coya Therapeutics | Neurology Rare | 1 | Phase 2 | $70.8M | 6 |
| PMN | ProMIS Neurosciences | Neurology Rare | 1 | Phase 1 | $28.9M | 9 |
| VYGR | Voyager Therapeutics | MetabolicNeurology Rare | 2 | Phase 1 | $94.6M | 9 |
No companies match.